Skip to content

5-Amino-1MQ

NNMT Inhibitor. Small molecule NNMT (nicotinamide N-methyltransferase) inhibitor. Blocks NNMT to elevate NAD+ and SAM, improve mitochondrial function, and reduce fat cell activity. Metabolic health, fat loss, NAD+ elevation.

Intelligence Profile

Safety Profile

Safety Profile

Evidence Limitation Notice: No published clinical trials, peer-reviewed studies, or established safety data were found for 5-Amino-1MQ in PubMed or clinical trial databases. The safety profile of this compound has not been established through rigorous scientific research.

Known Side Effects
Currently unknown. Without clinical trials or systematic safety studies, there is no reliable evidence documenting the side effects, adverse reactions, or safety profile of 5-Amino-1MQ in humans.

Contraindications
Not established. Due to the lack of clinical data, specific contraindications cannot be determined based on scientific evidence.

Drug Interactions
Unknown. No studies have evaluated potential interactions between 5-Amino-1MQ and other medications, supplements, or substances.

Populations That Should Avoid Use
Given the absence of safety data, the following populations should particularly avoid this compound:

  • Pregnant or breastfeeding women
  • Children and adolescents
  • Individuals with pre-existing medical conditions
  • Those taking prescription medications

Important Safety Considerations
The lack of published safety data means that potential risks, appropriate dosing, and long-term effects are completely unknown. This compound has not undergone the standard regulatory review processes that establish safety and efficacy for human use.

Disclaimer: This information is for educational purposes only and does not constitute medical advice. Consult with a healthcare provider before considering any unproven therapeutic compounds, especially those lacking established safety profiles.

Free account required

Safety profile requires a free AXIFI account to access clinical data, safety profiles, and research papers.